Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Matrion™ Decellularized Placental Membrane in Subjects With Diabetic Foot Ulcers

ClinicalTrials.gov ID: NCT05087758

Public ClinicalTrials.gov record NCT05087758. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 8:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Trial to Assess the Clinical Effectiveness of Matrion™ Decellularized Placental Membrane in Subjects With Diabetic Foot Ulcers

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

In this study, a novel placental membrane product Matrion™ (LifeNet Health, Inc., Virginia Beach, VA) will be used as a treatment for subjects with diabetic foot ulcers. Matrion is composed of placental membrane derived from donated human birth tissue containing both the innermost amniotic layer and the outermost chorionic layer, inclusive of the trophoblast layer. Matrion is minimally processed and disinfected using a proprietary decellularization technology and terminally sterilized that safely renders the placental membrane acellular and sterile for its intended surgical applications.

Study identification

NCT ID
NCT05087758
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
LifeNet Health
Industry
Enrollment
108 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2022
Primary completion
Dec 30, 2024
Completion
Feb 27, 2025
Last update posted
Apr 1, 2025

2022 – 2025

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
Compass Medical Research Center, LLC Tucson Arizona 85715
Center for Clinical Research, INC Carmichael California 95608
Limb Preservation Platform, INC Fresno California 93710
ILD Research Center San Diego California 92130
Center for Clinical Research, INC San Francisco California 94115
Doctors Research Network Miami Florida 33143
Albuquerque Associated Podiatrists Albuquerque New Mexico 87111
Purvis-Moyer Foot and Ankle Center Rocky Mount North Carolina 27804

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Diabetic Foot trials

Other public records listing Diabetic Foot. Sorted by last update posted; newest first. Not a recommendation.

All Diabetic Foot trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05087758, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2025 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05087758 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →